Sign in

CIK 0001701541

  • Non-accelerated filer
  • Smaller reporting company

Black Diamond Therapeutics, Inc.

Sign in to watch
Ticker
BDTX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
814254660
Phone
+1 617-417-5868
Business address
245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
Former names
Aset Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 48 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-12-16 INGRAM ROBERT ALEXANDER FORMER DIRECTOR Grant or award +9,375 $1.50 $14K 42,854
2022-09-16 INGRAM ROBERT ALEXANDER Director Grant or award +6,584 $2.62 $17K 33,479
2022-06-17 INGRAM ROBERT ALEXANDER Director Grant or award +8,498 $2.03 $17K 26,895
2022-06-10 INGRAM ROBERT ALEXANDER Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2022-03-18 INGRAM ROBERT ALEXANDER Director Grant or award +5,795 $3.02 $18K 18,397
2021-12-17 INGRAM ROBERT ALEXANDER Director Grant or award +3,296 $5.31 $18K 12,602
2021-09-17 INGRAM ROBERT ALEXANDER Director Grant or award +1,869 $9.90 $19K 9,306
2021-06-18 INGRAM ROBERT ALEXANDER Director Grant or award +1,255 $12.95 $16K 7,437
2021-06-18 INGRAM ROBERT ALEXANDER Director Grant or award · Stock Option (Right to Buy) +15,000 15,000
2021-03-18 INGRAM ROBERT ALEXANDER Director Grant or award +677 $24.01 $16K 6,182
2020-12-15 INGRAM ROBERT ALEXANDER Director Grant or award +505 $34.29 $17K 5,505

Page 1 of 1 · 11 trades